Skip to main content

EverQuote, Inc.

For the period ended Jun 30, 2026. Filed Aug 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 4, 2026

EVER$28.03-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Equity Securities

There were no equity securities sold by us during the three months ended June 30, 2026 that were not registered under the Securities Act, and that were not previously reported in a Current Report on Form 8-K.

Issuer Purchases of Equity Securities

The following table presents information with respect to shares of Class A common stock repurchased by EverQuote, Inc. during the three months ended June 30, 2026:

Total Number of Shares PurchasedAverage Price Paid Per Share (1)Total Number of Shares Purchased as Part of Publicly Announced ProgramApproximate Dollar Value of Shares That May Yet Be Purchased Under the Program (2)
(in thousands)
April 1, 2026 to April 30, 2026467,576$15.772,435,592$1,774
May 1, 2026 to May 31, 2026110,74616.022,546,338—
June 1, 2026 to June 30, 2026——2,546,338—
Total578,322$15.822,546,338$—

(1) Average price paid per share includes broker commissions and costs associated with the repurchase.

(2) On July 22, 2025, our board of directors authorized the repurchase of up to $50.0 million in shares of the Company’s Class A common stock. Repurchased shares are retired and resume the status of authorized but unissued shares of common stock.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.